Human ADME study of [14C]-Ceralasertib (AZD6738) and absolute bioavailability of Ceralasertib

Trial Identifier:	D533BC00002
Sponsor:	AstraZeneca
Start Date:	January 2025
Primary Completion Date:	August 2025
Study Completion Date:	August 2025
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Liverpool, GB, L7 8YA
GB	London, GB, NW1 2PG

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.